Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Adenoma”

253 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 253 results

Not applicableLooking for participantsNCT07072143
What this trial is testing

An International Study on Pediatric Patients With Rare Tumors.

Who this might be right for
Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more
Azienda Ospedaliera di Padova 6,250
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Early research (Phase 1)Looking for participantsNCT05687123
What this trial is testing

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Pancreatic Neuroendocrine TumorPancreatic NeoplasmStage III Pancreatic Neuroendocrine Tumor AJCC v8+2 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT05568017
What this trial is testing

Neoadjuvant PRRT With Y-90-DOTATOC in pNET

Who this might be right for
Pancreatic Neuroendocrine Tumor
European Institute of Oncology 11
Testing effectiveness (Phase 2)UnknownNCT03204019
What this trial is testing

Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Pancreatic Neuroendocrine Tumor
Chinese Academy of Medical Sciences 60
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT04291651
What this trial is testing

UCSF PANC Cyst Registry

Who this might be right for
Pancreatic CystPancreatic NeoplasmsPancreatic Cancer+5 more
University of California, San Francisco 4,000
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Not applicableWithdrawnNCT00671463
What this trial is testing

Pancreatic Stent to Prevent Leak After Distal Pancreatectomy

Who this might be right for
Pancreatic SurgeryPancreatic Duct StentingPancreatic Cancer+4 more
Massachusetts General Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Not applicableLooking for participantsNCT07273409
What this trial is testing

Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not

Who this might be right for
Pancreatic Neuroendocrine Tumor
Uppsala University 200
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableActive Not RecruitingNCT06406387
What this trial is testing

ATRX/DAXX in EUS-FNB Specimens of Pan-NETs

Who this might be right for
Pancreatic Neuroendocrine Tumor
Azienda Ospedaliera Universitaria Integrata Verona 100
Not applicableStudy completedNCT01401907
What this trial is testing

Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies

Who this might be right for
Non-small Cell Lung CancerSmall Cell Lung CancerMesothelioma+4 more
Massachusetts General Hospital 351
Testing effectiveness (Phase 2)Ended earlyNCT01583686
What this trial is testing

CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer

Who this might be right for
Cervical CancerPancreatic CancerOvarian Cancer+2 more
National Cancer Institute (NCI) 15
Not applicableStudy completedNCT00970970
What this trial is testing

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more
University Medical Center Groningen 22
Testing effectiveness (Phase 2)UnknownNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 44
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Testing effectiveness (Phase 2)Study completedNCT02259725
What this trial is testing

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
University of Southern California 3
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Load More Results